期刊
BIOLOGICAL & PHARMACEUTICAL BULLETIN
卷 38, 期 4, 页码 594-600出版社
PHARMACEUTICAL SOC JAPAN
DOI: 10.1248/bpb.b14-00752
关键词
G protein signal; agonistic antibody; adhesion G protein-coupled receptor (GPCR); glioma cell migration
资金
- Ministry of Education, Culture, Sports, Science and Technology of Japan [24590113, 25121724, 25293013]
- Takeda Science Foundation
- Grants-in-Aid for Scientific Research [24590113, 25293013] Funding Source: KAKEN
GPR56 is a member of the adhesion G protein-coupled receptor (GPCR) and is highly expressed in parts of tumor cells. The involvement of GPR56 in tumorigenesis has been reported. We generated agonistic monoclonal antibodies against human GPR56 and analyzed the action and signaling pathway of GPR56. The antibodies inhibited cell migration through the Gq and Rho pathway in human glioma U87-MG cells. Co-immunoprecipitation analysis indicated that the interaction between the GPR56 extracellular domain and transmembrane domain was potentiated by agonistic antibodies. These results demonstrated that functional antibodies are invaluable tools for GPCR research and should open a new avenue for therapeutic treatment of tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据